Nationwide quality assurance of rectal cancer treatment

Colorectal Disease

Volumn 8, Issue 3, 2006, Pages 224-229

  Wibe, Arne ^a   Carlsen, E ^b   Dahl, O ^c   Tveit, K M ^d   Weedon Fekjaer H ^e   Hestvik, U E ^e   Wiig, J N ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

Quality assurance; Rectal cancer

Indexed keywords

FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MONITORING; MULTIMODALITY CANCER THERAPY; NORWAY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUALITY CONTROL; RECTUM CANCER; RECTUM RESECTION; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NORWAY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE; RECTAL NEOPLASMS; REGISTRIES; SURVIVAL RATE;

EID: 33644927253     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2005.00924.x     Document Type: Article

References (19)

1. Wibe A, Møller B, Norstein J et al. A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision (TME) as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45: 857-66.
2. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br J Surg 1982; 69: 613-6.
3. Heald RJ, Ryall RDH. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; ii: 1479-82.
4. Martling A, Holm T, Rutquist L-E, Moran BJ, Heald RJ, Cedermark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 2000; 356: 93-6.
5. Martling A, Cedermark B, Johansson H, Rutquist LE, Holm T. The surgeon as a prognostic factor after the introduction of mesorectal excision in the treatment of rectal cancer. Br J Surg 2002; 89: 1008-13.
6. Wibe A, Svensson E, Bjerkeset T et al. The Norwegian Rectal Cancer Registry entails quality improvement in cancer treatment. Nor J Epidemiol 2001; 11: 159-63, (in Norwegian).
7. McArdle CS, Hole D. Impact of variability among surgeons on post-operative morbidity and mortality and ultimate survival. Br Med J 1991; 302: 1501-5.
8. Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum carcinoma - experience from the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori 1995; 81: 60-4.
9. Marusch F, Koch A, Schmidt U, Pross M, Gastinger I, Lippert H. Hospital caseload and the results achieved in patients with rectal cancer. Br J Surg 2001; 88: 1397-402.
10. Holm T, Johansson H, Cedermark B, Ekelund G, Rutquist L-E. In fluence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without radiotherapy. Br J Surg 1997; 84: 657-63.
11. Dowdall JF, Maguire D, McAnena OJ. Experience of surgery for rectal cancer with total mesorectal excision in a general surgical practice. Br J Surg 2002; 89: 1014-9.
12. Seow-Choen F. Adjuvant therapy for rectal cancer cannot be based on the results of other surgeons. Br J Surg 2002; 89: 946-7.
13. Smedh K, Olsson L, Johansson H, Åberg C, Andersson M. Reduction of postoperative morbidity and mortality inpatients with rectal cancer following the introduction of a colorectal unit. Br J Surg 2001; 88: 273-7.
14. Wibe A, Eriksen MT, Syse A, Tretli S, Myrvold HE, Søreide O. Effect of hospital caseload on long-term outcome after standardization of rectal cancer surgery at a national level. Br J Surg 2005; 92: 217-24.
15. Wibe A, Rendedal PR, Svensson E et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89: 327-34.
16. Quirke P, Dixon MF. How I do it: The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 1988; 3: 127-31.
17. Gibbs P, Chao MW, Tjandra JJ. Optimizing the Outcome for Patients with Rectal Cancer. Dis Colon Rectum 2003; 46: 389-402.
18. Kapiteijn E, Marijnen CAM, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-46.
19. Dahl O, Horn A, Morild I et al. Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Cancer 1990; 66: 2286-94.